Caris Detect
Blood-based multi-cancer early detection LDT using whole-genome and whole-transcriptome sequencing with AI.
- Developer
- Caris Life Sciences
- Intended use
- Multi Cancer Screening
- Cancer scope
- Liver cancer, Ovarian cancer, Pancreatic cancer
- Specimen
- Peripheral whole blood
- Molecular modality
- Multi-omics
- Current version
- Caris Detect current commercial configuration (2026)
- Evidence context
- 1 structured studies · 6 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.